Skip to main content
. 2021 Oct 22;11:20886. doi: 10.1038/s41598-021-00389-1

Figure 1.

Figure 1

Electrodiagnostic studies to measure latency and amplitude (a) (Sham, sham-operated mice; PBS, untreated mice during compression phase; CF, mice treated with clemastine during compression phase; d-PBS, untreated mice after surgical decompression; d-CF, mice treated with clemastine after surgical decompression). Serial measurements of latency and CMAP amplitude during 6 weeks of compression phase in mice with compression neuropathy (b,c) and during 2 weeks of decompression phase in mice taken surgical decompression (d,e). Error bars represent standard error of mean. Two-way ANOVA with Turkey’s post-hoc test was conducted. A significant difference (*p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001) versus PBS (control) or d-PBS group (n = 10 animals/group).